*Disclaimer

EXOPHARM LIMITED (ASX: EX1)

🔗 📄 📈

EX1: EX1 early stage success with in house Elastin (ELN) program

EXOPHARM LIMITED

2023-04-28 08:03:00

EX1: Exopharm Limited announces Non-Renounceable Pro Rata Rights

EXOPHARM LIMITED

2023-03-23 08:37:00

EX1: EX1 to Receive $0.431m in Prepayment of R&D Tax Incentive

EXOPHARM LIMITED

2023-03-09 08:10:00